HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianxin Li Selected Research

distal type 2 Arthrogryposis multiplex congenita

1/2015Two novel mutations in myosin binding protein C slow causing distal arthrogryposis type 2 in two large Han Chinese families may suggest important functional role of immunoglobulin domain C2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianxin Li Research Topics

Disease

14Hypertension (High Blood Pressure)
01/2022 - 08/2012
13Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2012
11Neoplasms (Cancer)
01/2022 - 11/2005
5Obesity
10/2021 - 05/2009
5Inflammation (Inflammations)
01/2018 - 01/2012
4Stroke (Strokes)
01/2021 - 01/2019
4Pre-Eclampsia (Preeclampsia)
08/2020 - 11/2016
3Thrombosis (Thrombus)
01/2020 - 12/2016
3Necrosis
01/2019 - 11/2007
3Body Weight (Weight, Body)
06/2017 - 03/2013
3Aneurysm (Aneurysms)
10/2016 - 09/2008
3Arthrogryposis
01/2015 - 05/2007
3Immune System Diseases (Immune Disorders)
06/2013 - 03/2007
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2021
2Overweight
10/2021 - 05/2009
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 01/2020
2COVID-19
01/2021 - 01/2020
2Myocardial Infarction
12/2020 - 01/2019
2Lung Neoplasms (Lung Cancer)
12/2020 - 08/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 10/2014
2Pneumonia (Pneumonitis)
01/2020 - 01/2020
2Coronary Disease (Coronary Heart Disease)
01/2020 - 07/2009
2Major Depressive Disorder (Major Depressive Disorders)
01/2020 - 01/2017
2Carcinogenesis
01/2020 - 03/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2015
2Mental Disorders (Mental Disorder)
01/2020 - 07/2014
2Infections
01/2020 - 06/2016
2Hemorrhagic Stroke
12/2019 - 12/2019
2Osteoarthritis
02/2019 - 05/2018
2Abdominal Obesity
01/2018 - 07/2014
2Genetic Risk Score
12/2017 - 02/2016
2Rupture
09/2017 - 12/2016
2Hypoxia (Hypoxemia)
11/2016 - 03/2013
2Atherosclerosis
08/2016 - 07/2009
2Weight Gain
07/2016 - 03/2013
2Weight Loss (Weight Reduction)
04/2016 - 11/2014
2Contact Dermatitis (Eczema, Contact)
11/2014 - 03/2007
2Osteosarcoma (Osteogenic Sarcoma)
01/2014 - 04/2011
2Pain (Aches)
12/2013 - 04/2013
2Contracture
09/2013 - 05/2007
2Ischemia
03/2013 - 03/2009
1Pharyngitis (Sore Throat)
03/2022
1Dehydration (Water Stress)
12/2021
1Acute Promyelocytic Leukemia
10/2021

Drug/Important Bio-Agent (IBA)

9Particulate MatterIBA
01/2022 - 01/2019
7Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2004
6Glucose (Dextrose)FDA LinkGeneric
01/2018 - 05/2009
5CytokinesIBA
03/2022 - 11/2014
5Pharmaceutical PreparationsIBA
01/2022 - 11/2005
5Long Noncoding RNAIBA
01/2021 - 01/2020
52- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2015 - 08/2012
4TeaIBA
03/2022 - 04/2014
4LipidsIBA
01/2022 - 02/2016
4Messenger RNA (mRNA)IBA
01/2022 - 08/2008
4SaltsIBA
12/2021 - 07/2015
4Competitive Endogenous RNAIBA
01/2021 - 01/2020
4HDL CholesterolIBA
01/2021 - 10/2015
4EnzymesIBA
10/2020 - 04/2016
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2016
3MicroRNAs (MicroRNA)IBA
01/2021 - 03/2016
3InflammasomesIBA
03/2020 - 05/2013
3amsonic acid (DAS)IBA
01/2015 - 05/2007
2RNA (Ribonucleic Acid)IBA
01/2022 - 08/2008
2Blood Glucose (Blood Sugar)IBA
01/2021 - 06/2017
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 03/2013
2ProcalcitoninIBA
01/2021 - 01/2020
2C-Reactive ProteinIBA
01/2020 - 01/2020
2Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 10/2014
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 02/2015
2LDL CholesterolIBA
12/2019 - 10/2015
2Triglycerides (Triacylglycerol)IBA
12/2019 - 01/2018
2PotassiumIBA
12/2017 - 10/2012
2PolymersIBA
09/2017 - 03/2016
2ApigeninIBA
01/2017 - 07/2016
2Protein Isoforms (Isoforms)IBA
11/2016 - 05/2007
2AntigensIBA
06/2016 - 11/2007
2Sucrose (Saccharose)IBA
02/2016 - 03/2013
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2016 - 07/2009
22- (3,4- dimethoxybenzyl)- 7- (1- (1- hydroxyethyl)- 4- phenylbutyl)- 5- methylimidazo(5,1- f)(1,2,4)triazin- 4 (3H)-oneIBA
02/2015 - 07/2014
2ferulic acid (sodium ferulate)IBA
02/2015 - 12/2013
2Annexin A5IBA
01/2014 - 04/2011
23'-O-methylastilbinIBA
06/2013 - 03/2007
2astilbinIBA
06/2013 - 03/2007
1lipoarabinomannan (LAM)IBA
03/2022
1AmmoniaIBA
03/2022
1Ethanol (Ethyl Alcohol)IBA
03/2022
1Complex MixturesIBA
03/2022
1cyclo(Arg-Pro) (CI 4)IBA
01/2022
1A 17 (A-17)IBA
01/2022
1IonsIBA
12/2021
1SodiumIBA
12/2021
1Antihypertensive Agents (Antihypertensives)IBA
11/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2021

Therapy/Procedure

6Therapeutics
11/2021 - 03/2016
6Stents
01/2019 - 02/2012
3Drug Therapy (Chemotherapy)
09/2021 - 01/2014
2Punctures
01/2020 - 12/2016
2Lasers (Laser)
06/2016 - 03/2016
1Immunotherapy
01/2022